A carregar...

Checkpoint modulation - A new way to direct the immune system against renal cell carcinoma

The introduction of targeted therapies like the tyrosine kinase (TKI) and mammalian target of rapamycin (mTOR) inhibitors has improved patients´ survival in general. Nevertheless the prognosis remains limited. Therapies with a new mode of action are urgently warranted, especially those who would pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Bedke, Jens, Kruck, Stephan, Gakis, Georgios, Stenzl, Arnulf, Goebell, Peter J
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514323/
https://ncbi.nlm.nih.gov/pubmed/25912622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1016657
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!